This Nov 3rd, join us for the third edition of Business of Cannabis: New York at The Williamsburg Hotel. A day long leadership summit focused on retail, investment & policy across New York and North America. Tickets on-sale now – www.cannabisnewyork.live
New figures from the Illinois Department of Financial and Professional Regulation (IDFPR) show that adult-use cannabis sales broke records for the second consecutive month in September, but growth has slowed to a crawl.
Last month the number of items sold in the state hit 3.68m, edging ahead of the previous record of 3.64m in August.
Despite being the highest amount of items sold, September was only the third highest month on record when it came to revenues.
Throughout the month, adult-use sales hit $139.5m, up just 0.2% from the $139.2m reported in August, and nearly 7% on the same period last year.
Sales to non-residents of the state accounted for $34.5m during the month, representing 24.6% of the total, up marginally on August.
This represents growth of around 5% in the first 9 months of 2023, according to New Cannabis Ventures, following growth of 13% in 2022 and 106% in 2021
Illinois also published the sales figures for its medical cannabis market, revealing that 296,536 patient applications have now been approved since the programme began in 2014, with the total number of active patients now sitting at 138,837.
Medical cannabis retail sales for September hit $26m, including $12.5m from dry flower sales and $13.5m from concentrates and infused products.
This represented a 7.3% year-on-year decline, and a 1.7% fall on the previous month.
